Clinical trial
A Multi-national, Prospective Mixed Methods Study of the Effectiveness of Naloxone (Including Intranasal Nyxoid) Administration by Lay People in Reversing Opioid Overdose
NCT05072249 is registered in ClinicalTrials.gov with King's College London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-national, Prospective Mixed Methods Study of the Effectiveness of Naloxone (Including Intranasal Nyxoid) Administration by Lay People in Reversing Opioid Overdose
- Lead sponsor
- King's College London
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 8, 2021
- Completion date
- December 30, 2023
- Enrollment
- 6,000 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
opioid overdose